# Proteinuria in Renal Transplant Patients Treated With Dapagliflozin

> **NCT06165601** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 55 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **PROCEDURE:** Follow-up at D14
- **PROCEDURE:** Follow-up at M1

## Key facts

- **NCT ID:** NCT06165601
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-04
- **Primary completion:** 2025-10-25
- **Final completion:** 2025-10-25
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06165601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06165601, "Proteinuria in Renal Transplant Patients Treated With Dapagliflozin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06165601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*